Concepedia

Anne E. Reed‐Hagen

AE

3

Publications

405

Citations

3

H-Index

1999

Active since

Affiliations

Pfizer (United States)(Current)

Anne E. Reed‐Hagen is an author at Pfizer (United States) specializing in hepatology, pharmacotherapy, and drug discovery.

Top concepts

HealthMedicineHepatologyPhysiologyToxicologyBiochemistryPharmacologyDrug DiscoveryPharmacotherapyLiver Physiology

Publications per year

1999–2005

3

Publications

3

METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO

R. Scott Obach, Anne E. Reed‐Hagen, Suzanne S Krueger et al. · Drug Metabolism and Disposition · 2005 · 200 citations

Measurement of Michaelis Constants for Cytochrome P450-Mediated Biotransformation Reactions Using a Substrate Depletion Approach

R. Scott Obach, Anne E. Reed‐Hagen · Drug Metabolism and Disposition · 2002 · 187 citations

Pharmacokinetics of ezlopitant, a novel non-peptidic neurokinin-1 receptor antagonist in preclinical species and metabolite kinetics of the pharmacologically active metabolites

Anne E. Reed‐Hagen, Megumi Tsuchiya, Kaoru Shimada et al. · Biopharmaceutics & Drug Disposition · 1999 · 18 citations

Active Metabolites, Pharmacotherapy, Experimental Pharmacology +19

Rows per page

1–3 of 3